These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 27161818

  • 1. Comparison of Different Risk Scores for Predicting Contrast Induced Nephropathy and Outcomes After Primary Percutaneous Coronary Intervention in Patients With ST Elevation Myocardial Infarction.
    Liu YH, Liu Y, Zhou YL, He PC, Yu DQ, Li LW, Xie NJ, Guo W, Tan N, Chen JY.
    Am J Cardiol; 2016 Jun 15; 117(12):1896-903. PubMed ID: 27161818
    [Abstract] [Full Text] [Related]

  • 2. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Andò G, Morabito G, de Gregorio C, Trio O, Saporito F, Oreto G.
    Catheter Cardiovasc Interv; 2013 Nov 15; 82(6):878-85. PubMed ID: 23703775
    [Abstract] [Full Text] [Related]

  • 3. A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes.
    Zeng JF, Chen SQ, Ye JF, Chen Y, Lei L, Liu XQ, Liu Y, Wang Y, Lin JJ, Chen JY.
    Clin Exp Nephrol; 2019 Jul 15; 23(7):969-981. PubMed ID: 31049747
    [Abstract] [Full Text] [Related]

  • 4. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
    Nakahashi H, Kosuge M, Sakamaki K, Kiyokuni M, Ebina T, Hibi K, Tsukahara K, Iwahashi N, Kuji S, Oba MS, Umemura S, Kimura K.
    Heart Vessels; 2017 Jan 15; 32(1):22-29. PubMed ID: 27106917
    [Abstract] [Full Text] [Related]

  • 5. A novel risk score model for prediction of contrast-induced nephropathy after emergent percutaneous coronary intervention.
    Lin KY, Zheng WP, Bei WJ, Chen SQ, Islam SM, Liu Y, Xue L, Tan N, Chen JY.
    Int J Cardiol; 2017 Mar 01; 230():402-412. PubMed ID: 28043662
    [Abstract] [Full Text] [Related]

  • 6. Canada Acute Coronary Syndrome Score: A Preprocedural Risk Score for Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.
    Liu YH, Jiang L, Duan CY, He PC, Liu Y, Tan N, Chen JY.
    Angiology; 2017 Oct 01; 68(9):782-789. PubMed ID: 28135823
    [Abstract] [Full Text] [Related]

  • 7. A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Centola M, Lucreziotti S, Salerno-Uriarte D, Sponzilli C, Ferrante G, Acquaviva R, Castini D, Spina M, Lombardi F, Cozzolino M, Carugo S.
    Int J Cardiol; 2016 May 01; 210():4-9. PubMed ID: 26921538
    [Abstract] [Full Text] [Related]

  • 8. The association of PRECISE-DAPT score with development of contrast-induced nephropathy in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Çınar T, Tanık VO, Aruğaslan E, Karabağ Y, Çağdaş M, Rencüzoğulları İ, Keskin M.
    Cardiovasc Interv Ther; 2019 Jul 01; 34(3):207-215. PubMed ID: 30191494
    [Abstract] [Full Text] [Related]

  • 9. Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.
    Oksuz F, Yarlioglues M, Cay S, Celik IE, Mendi MA, Kurtul A, Cankurt T, Kuyumcu S, Canpolat U, Turak O.
    Am J Cardiol; 2015 Sep 01; 116(5):711-6. PubMed ID: 26116992
    [Abstract] [Full Text] [Related]

  • 10. Utility of the Logistic Clinical Syntax Score in the Prediction of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.
    Ozturk D, Celik O, Erturk M, Kalkan AK, Uzun F, Akturk IF, Akin F, Yildirim A.
    Can J Cardiol; 2016 Feb 01; 32(2):240-6. PubMed ID: 26255218
    [Abstract] [Full Text] [Related]

  • 11. Association of Serum Osmolarity With Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction.
    Yildiz I, Yildiz PO, Rencuzogullari I, Karabag Y, Cagdas M, Burak C, Gurevin MS.
    Angiology; 2019 Aug 01; 70(7):627-632. PubMed ID: 30712366
    [Abstract] [Full Text] [Related]

  • 12. Simplifying contrast-induced acute kidney injury prediction after primary percutaneous coronary intervention: the age, creatinine and ejection fraction score.
    Araujo GN, Pivatto Junior F, Fuhr B, Cassol EP, Machado GP, Valle FH, Bergoli LC, Wainstein RV, Polanczyk CA, Wainstein MV.
    Cardiovasc Interv Ther; 2018 Jul 01; 33(3):224-231. PubMed ID: 28540634
    [Abstract] [Full Text] [Related]

  • 13. Fragmented QRS complex predicts contrast-induced nephropathy and in-hospital mortality after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Kurtul A, Duran M.
    Clin Cardiol; 2017 Apr 01; 40(4):235-242. PubMed ID: 28244599
    [Abstract] [Full Text] [Related]

  • 14. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
    Mager A, Vaknin Assa H, Lev EI, Bental T, Assali A, Kornowski R.
    Catheter Cardiovasc Interv; 2011 Aug 01; 78(2):198-201. PubMed ID: 20949583
    [Abstract] [Full Text] [Related]

  • 15. Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment.
    Pyxaras SA, Sinagra G, Mangiacapra F, Perkan A, Di Serafino L, Vitrella G, Rakar S, De Vroey F, Santangelo S, Salvi A, Toth G, Bartunek J, De Bruyne B, Wijns W, Barbato E.
    Am J Cardiol; 2013 Mar 01; 111(5):684-8. PubMed ID: 23261003
    [Abstract] [Full Text] [Related]

  • 16. Does N-terminal pro-brain natriuretic peptide add prognostic value to the Mehran risk score for contrast-induced nephropathy and long-term outcomes after primary percutaneous coronary intervention?
    Liu YH, Jiang L, Chen JY, Tan N, Liu Y, He PC.
    Int Urol Nephrol; 2016 Oct 01; 48(10):1675-82. PubMed ID: 27473154
    [Abstract] [Full Text] [Related]

  • 17. Diastolic dysfunction predicts the risk of contrast-induced nephropathy and outcome post-emergency percutaneous coronary intervention in AMI patients with preserved ejection fraction.
    Han B, Li Y, Dong Z, Wan Q, Shen H, Li J, Wei M, Shen C.
    Heart Vessels; 2018 Oct 01; 33(10):1149-1158. PubMed ID: 29704102
    [Abstract] [Full Text] [Related]

  • 18. Is atrial fibrillation a risk factor for contrast-induced nephropathy in patients with ST-elevation myocardial infarction?
    Ballı M, Taşolar H, Çetin M, Hatem E, Çağlıyan ÇE, Şeker T, Çaylı M.
    J Cardiol; 2016 Apr 01; 67(4):327-30. PubMed ID: 26589269
    [Abstract] [Full Text] [Related]

  • 19. The ratio of contrast volume to glomerular filtration rate predicts in-hospital and six-month mortality in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
    Çiçek G, Bozbay M, Açıkgöz SK, Altay S, Uğur M, Köroğlu B, Uyarel H.
    Cardiol J; 2015 Apr 01; 22(1):101-7. PubMed ID: 24671903
    [Abstract] [Full Text] [Related]

  • 20. Predictive value of ATRIA risk score for contrast-induced nephropathy after percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Aksoy F, Bagcı A.
    Rev Assoc Med Bras (1992); 2019 Nov 01; 65(11):1384-1390. PubMed ID: 31800901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.